163 related articles for article (PubMed ID: 24970760)
21. p27
Jeannot P; Nowosad A; Perchey RT; Callot C; Bennana E; Katsube T; Mayeux P; Guillonneau F; Manenti S; Besson A
Elife; 2017 Mar; 6():. PubMed ID: 28287395
[TBL] [Abstract][Full Text] [Related]
22. Actinin-1 and actinin-4 play essential but distinct roles in invadopodia formation by carcinoma cells.
Yamaguchi H; Ito Y; Miura N; Nagamura Y; Nakabo A; Fukami K; Honda K; Sakai R
Eur J Cell Biol; 2017 Oct; 96(7):685-694. PubMed ID: 28797528
[TBL] [Abstract][Full Text] [Related]
23. Podocalyxin-Like Protein 1 Regulates Pluripotency through the Cholesterol Biosynthesis Pathway.
Chen WJ; Huang WK; Pather SR; Chang WF; Sung LY; Wu HC; Liao MY; Lee CC; Wu HH; Wu CY; Liao KS; Lin CY; Yang SC; Lin H; Lai PL; Ng CH; Hu CM; Chen IC; Chuang CH; Lai CY; Lin PY; Lee YC; Schuyler SC; Schambach A; Lu FL; Lu J
Adv Sci (Weinh); 2022 Nov; 10(1):e2205451. PubMed ID: 36373710
[TBL] [Abstract][Full Text] [Related]
24. Cortactin releases the brakes in actin- based motility by enhancing WASP-VCA detachment from Arp2/3 branches.
Siton O; Ideses Y; Albeck S; Unger T; Bershadsky AD; Gov NS; Bernheim-Groswasser A
Curr Biol; 2011 Dec; 21(24):2092-7. PubMed ID: 22169534
[TBL] [Abstract][Full Text] [Related]
25. Tyrosine 397 phosphorylation is critical for FAK-promoted Rac1 activation and invasive properties in oral squamous cell carcinoma cells.
Chiu YW; Liou LY; Chen PT; Huang CM; Luo FJ; Hsu YK; Yuan TC
Lab Invest; 2016 Mar; 96(3):296-306. PubMed ID: 26752742
[TBL] [Abstract][Full Text] [Related]
26. Podocalyxin-like protein, linked to poor prognosis of pancreatic cancers, promotes cell invasion by binding to gelsolin.
Taniuchi K; Furihata M; Naganuma S; Dabanaka K; Hanazaki K; Saibara T
Cancer Sci; 2016 Oct; 107(10):1430-1442. PubMed ID: 27461278
[TBL] [Abstract][Full Text] [Related]
27. Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase Calpha and the PDZ adapter protein mda-9/Syntenin.
Hwangbo C; Kim J; Lee JJ; Lee JH
Cancer Res; 2010 Feb; 70(4):1645-55. PubMed ID: 20145126
[TBL] [Abstract][Full Text] [Related]
28. Cdc42 negatively regulates intrinsic migration of highly aggressive breast cancer cells.
Zuo Y; Wu Y; Chakraborty C
J Cell Physiol; 2012 Apr; 227(4):1399-407. PubMed ID: 21618528
[TBL] [Abstract][Full Text] [Related]
29. Denbinobin, a phenanthrene from Dendrobium nobile, impairs prostate cancer migration by inhibiting Rac1 activity.
Lu TL; Han CK; Chang YS; Lu TJ; Huang HC; Bao BY; Wu HY; Huang CH; Li CY; Wu TS
Am J Chin Med; 2014; 42(6):1539-54. PubMed ID: 25427623
[TBL] [Abstract][Full Text] [Related]
30. Formation of extracellular matrix-digesting invadopodia by primary aortic smooth muscle cells.
Furmaniak-Kazmierczak E; Crawley SW; Carter RL; Maurice DH; Côté GP
Circ Res; 2007 May; 100(9):1328-36. PubMed ID: 17446433
[TBL] [Abstract][Full Text] [Related]
31. Epigallocatechin-3 gallate inhibits cancer invasion by repressing functional invadopodia formation in oral squamous cell carcinoma.
Hwang YS; Park KK; Chung WY
Eur J Pharmacol; 2013 Sep; 715(1-3):286-95. PubMed ID: 23707351
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of invadopodia formation by diosgenin in tumor cells.
Lian Y; Wen D; Meng X; Wang X; Li H; Hao L; Xue H; Zhao J
Oncol Lett; 2020 Dec; 20(6):283. PubMed ID: 33014161
[TBL] [Abstract][Full Text] [Related]
33. Targeting invadopodia-mediated breast cancer metastasis by using ABL kinase inhibitors.
Meirson T; Genna A; Lukic N; Makhnii T; Alter J; Sharma VP; Wang Y; Samson AO; Condeelis JS; Gil-Henn H
Oncotarget; 2018 Apr; 9(31):22158-22183. PubMed ID: 29774130
[TBL] [Abstract][Full Text] [Related]
34. High expression of FBP17 in invasive breast cancer cells promotes invadopodia formation.
Suman P; Mishra S; Chander H
Med Oncol; 2018 Apr; 35(5):71. PubMed ID: 29651632
[TBL] [Abstract][Full Text] [Related]
35. P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation.
Ching YP; Leong VY; Lee MF; Xu HT; Jin DY; Ng IO
Cancer Res; 2007 Apr; 67(8):3601-8. PubMed ID: 17440071
[TBL] [Abstract][Full Text] [Related]
36. Hyperphosphorylated cortactin in cancer cells plays an inhibitory role in cell motility.
Jia L; Uekita T; Sakai R
Mol Cancer Res; 2008 Apr; 6(4):654-62. PubMed ID: 18403644
[TBL] [Abstract][Full Text] [Related]
37. Cortactin promotes cell motility by enhancing lamellipodial persistence.
Bryce NS; Clark ES; Leysath JL; Currie JD; Webb DJ; Weaver AM
Curr Biol; 2005 Jul; 15(14):1276-85. PubMed ID: 16051170
[TBL] [Abstract][Full Text] [Related]
38. Ca
Xue Y; Li M; Hu J; Song Y; Guo W; Miao C; Ge D; Hou Y; Wang X; Huang X; Liu T; Zhang X; Huang Q
Cell Death Dis; 2022 Sep; 13(9):812. PubMed ID: 36137995
[TBL] [Abstract][Full Text] [Related]
39. Inhibiting FAK-Paxillin Interaction Reduces Migration and Invadopodia-Mediated Matrix Degradation in Metastatic Melanoma Cells.
Mousson A; Legrand M; Steffan T; Vauchelles R; Carl P; Gies JP; Lehmann M; Zuber G; De Mey J; Dujardin D; Sick E; Rondé P
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33919725
[TBL] [Abstract][Full Text] [Related]
40. HDAC6 is required for invadopodia activity and invasion by breast tumor cells.
Rey M; Irondelle M; Waharte F; Lizarraga F; Chavrier P
Eur J Cell Biol; 2011; 90(2-3):128-35. PubMed ID: 20970878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
